UK bio pharma: Innovation re invention and capital at risk

Colin Haslam, N. Tsitsianis, Pauline Gleadle

Research output: Book/ReportCommissioned report


Small and medium enterprise (SME) bio-pharmas play a significant role
in the development of a knowledge-based competitive economy because
they act as an incubator of creativity for the development of pharmabased
products which they steer towards regulatory approval. Their
contribution is predominantly the development of new pharmaceutical
products which can then be licensed or sold on to big-pharma.
Original languageEnglish
PublisherInstitute of Chartered Accountants of Scotland
Number of pages57
ISBN (Print)978-1-904574-79-8
Publication statusPublished - Jul 2011


Dive into the research topics of 'UK bio pharma: Innovation re invention and capital at risk'. Together they form a unique fingerprint.

Cite this